Challenger Finally Gets the Regulatory Reform It Waited 20 Years For

Fund managers say APRA's finalised capital rules could unlock significant shareholder returns, though some want to see growth follow

30 Jun 2026 · 4 min read

After two decades of hoped-for regulatory reform, Challenger finally got the capital rule changes fund managers say could unlock hundreds of millions of dollars for shareholders and reshape Australia's retirement income market.

A long-awaited regulatory reform arrives

PM Capital's October 2025 update flagged the catalyst: APRA released proposed new capital rules aimed at reducing capital requirements for the retirement income market, reforms Challenger had strongly supported and stood to benefit from. Ten Cap's February 2026 case laid out the combination it found compelling: an ageing population driving enormous demand for retirement income solutions, a regulatory change letting Challenger carry less capital and fund more buybacks from July 2026, and a stock still trading at a discount to its historical earnings multiple and peers.

Aging population is driving enormous amount of demand for retirement income solutions, and Challenger is one of the easiest and purest way to play that. APRA just made some capital changes, so from 1st of July, Challenger can now carry less capital. This means more buyback, high return on equities, and more growth to come.

— Ten Cap, Presentation, February 2026

Finalised rules confirm the capital benefit

PM Capital's March 2026 quarterly update reported APRA had finalised the new capital standards for annuity products, effective 1 July 2026, reducing the capital Challenger must hold against its lifetime annuity book and supporting a higher return on equity. Pendal Group's April update showed the first tangible outcome, an on-market buyback tracking toward $300 million to $400 million as a day-one benefit of the reform, even as the company's own third-quarter guidance was trimmed slightly on fund management outflows.

A rejected acquisition shows capital discipline

Pendal Group's March 2026 update noted Challenger's reduced bid for Pepper Money had been rejected and would not proceed, after the market had been dubious about why an equity stake was required to secure securitisation deal flow. Pendal saw the discipline as encouraging, since day-one capital reform benefits were now more likely to flow fully to shareholders rather than be redirected into an uncertain acquisition.

Managers split on how much growth is still needed

Alliance Bernstein's May 2026 view was unambiguously bullish after decades of covering the stock, describing Challenger as finally getting the regulatory reform it had waited years for and calling it a strong buy given the improving product and rate environment. Paradice Investment Management was more measured, rating the stock a hold and wanting to see a genuine step change in annuity adoption from superannuation funds and insurers before fully embracing the reform story, describing Challenger's ideal operating backdrop as a narrow Goldilocks zone of moderate but not excessive credit spread volatility.

For 20 years, they were frustrated. It was like Groundhog Day. Every year you'd turn up and they'd go, 'We're going to get regulatory reform this year,' and it wouldn't happen. But it's finally happened right now. Challenger got their regulatory reform, and they're a better company now as a result of it.

— Alliance Bernstein, Article, May 2026

A cautious investor day disappoints on the detail

Pendal Group's June 2026 update showed the reform story hitting a speed bump: Challenger's investor day confirmed a further $300 million buyback, taking total day-one benefits to $450 million, but gave no detail on potential day-two impacts, including a possible shift from 75 per cent to more than 85 per cent fixed income holdings that could liberate a further $1 billion of capital. Pendal noted management appeared to prefer staging benefits over time to fund growth rather than distributing everything immediately, a strategy it saw as the most value-accretive path if executed well, even as the market remained sceptical of Challenger's historical track record on growth and innovation.